X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DISHMAN PHARMA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DISHMAN PHARMA PFIZER/
DISHMAN PHARMA
 
P/E (TTM) x 24.2 25.1 96.6% View Chart
P/BV x 3.9 3.3 115.1% View Chart
Dividend Yield % 0.8 0.7 126.6%  

Financials

 PFIZER   DISHMAN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-16
DISHMAN PHARMA
Mar-16
PFIZER/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,724374 727.6%   
Low Rs1,611129 1,249.8%   
Sales per share (Unadj.) Rs440.9197.8 222.9%  
Earnings per share (Unadj.) Rs48.721.2 229.6%  
Cash flow per share (Unadj.) Rs75.834.7 218.2%  
Dividends per share (Unadj.) Rs15.002.00 750.0%  
Dividend yield (eoy) %0.70.8 87.1%  
Book value per share (Unadj.) Rs462.9179.9 257.3%  
Shares outstanding (eoy) m45.7580.69 56.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.3 386.4%   
Avg P/E ratio x44.511.9 375.1%  
P/CF ratio (eoy) x28.67.2 394.7%  
Price / Book Value ratio x4.71.4 334.7%  
Dividend payout %30.89.4 326.6%   
Avg Mkt Cap Rs m99,16320,306 488.4%   
No. of employees `0002.90.8 348.5%   
Total wages/salary Rs m2,7585,355 51.5%   
Avg. sales/employee Rs Th6,981.719,252.7 36.3%   
Avg. wages/employee Rs Th954.56,459.5 14.8%   
Avg. net profit/employee Rs Th771.12,064.1 37.4%   
INCOME DATA
Net Sales Rs m20,17015,961 126.4%  
Other income Rs m857265 323.1%   
Total revenues Rs m21,02816,226 129.6%   
Gross profit Rs m4,3104,103 105.0%  
Depreciation Rs m1,2391,091 113.6%   
Interest Rs m5944 0.6%   
Profit before tax Rs m3,9232,334 168.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794624 287.7%   
Profit after tax Rs m2,2281,711 130.2%  
Gross profit margin %21.425.7 83.1%  
Effective tax rate %45.726.7 171.2%   
Net profit margin %11.010.7 103.0%  
BALANCE SHEET DATA
Current assets Rs m16,29911,018 147.9%   
Current liabilities Rs m7,5949,517 79.8%   
Net working cap to sales %43.29.4 458.9%  
Current ratio x2.11.2 185.4%  
Inventory Days Days65110 59.1%  
Debtors Days Days2635 73.9%  
Net fixed assets Rs m8,62216,304 52.9%   
Share capital Rs m458161 283.5%   
"Free" reserves Rs m20,72212,907 160.6%   
Net worth Rs m21,18014,516 145.9%   
Long term debt Rs m254,189 0.6%   
Total assets Rs m29,13729,805 97.8%  
Interest coverage x755.53.5 21,765.6%   
Debt to equity ratio x00.3 0.4%  
Sales to assets ratio x0.70.5 129.3%   
Return on assets %7.78.9 86.0%  
Return on equity %10.511.8 89.2%  
Return on capital %19.017.5 108.3%  
Exports to sales %0.124.8 0.2%   
Imports to sales %17.53.7 467.9%   
Exports (fob) Rs m123,956 0.3%   
Imports (cif) Rs m3,526596 591.3%   
Fx inflow Rs m524,952 1.0%   
Fx outflow Rs m140697 20.1%   
Net fx Rs m-884,255 -2.1%   
CASH FLOW
From Operations Rs m3,4362,786 123.3%  
From Investments Rs m-6,991-1,529 457.3%  
From Financial Activity Rs m-619-941 65.8%  
Net Cashflow Rs m-4,174316 -1,319.1%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 4.9 12.7 38.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 22.1 107.2%  
Shareholders   85,207 46,261 184.2%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DR. DATSONS LABS  STRIDES SHASUN LTD  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 16, 2017 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS